Adjuvant Toripalimab Plus Chemotherapy for EGFR/ALK Mutation Negative Stage II-IIIB(N2) NSCLC (LungMate-008)
Clinical trial NCT04772287 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT04772287
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-31
- Primary completion
- 2026-12-30
- Enrollment
- 341
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.